John Hopkins Hospital
Baltimore, Maryland 21287
We've found
9 trials
at this facility
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent Glioblastoma Multiforme (GBM)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Pulmonary Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
Standardized Treatment of Pulmonary Exacerbations II
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Depressive Disorder, Treatment-Resistant Clinical Trial
Updated: 12/31/1969
A Long-term Safety Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Subjects With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumor Clinical Trial
Updated: 12/31/1969
Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials